NASDAQ: KDLYKindly MD Inc Stock
$1.37-0.22 (-13.84%)
Updated Dec 9, 2024
KDLY Price
$1.37
Fair Value Price
N/A
Market Cap
$8.19M
52 Week Low
$0.65
52 Week High
$4.20
P/E
-2.45x
P/B
2.35x
P/S
2.17x
PEG
N/A
Dividend Yield
N/A
Revenue
$2.88M
Earnings
-$2.94M
Gross Margin
93.9%
Operating Margin
-86.94%
Profit Margin
-102.3%
Debt to Equity
0.24
Operating Cash Flow
-$2M
Beta
0.88
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
KDLY Overview
Kindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine KDLY's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
D
Value
C
Growth
D
Momentum
C
Sentiment
D
Safety
D
Financials
D
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
C
KDLY
Ranked#44 of 52
Ranked#44 of 52
Be the first to know about important KDLY news, forecast changes, insider trades & much more!
KDLY News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how KDLY scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
KDLY is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
KDLY is good value based on its book value relative to its share price (2.35x), compared to the US Health Information Services industry average (3.86x)
P/B vs Industry Valuation
KDLY is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more KDLY due diligence checks available for Premium users.
Valuation
KDLY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.45x
Industry
24.56x
Market
29.44x
KDLY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.35x
Industry
3.86x
KDLY is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
KDLY's financial health
Profit margin
Revenue
$647.9k
Net Income
-$1.0M
Profit Margin
-156.5%
KDLY's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
KDLY's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$4.3M
Liabilities
$840.1k
Debt to equity
0.24
KDLY's short-term assets ($3.94M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
KDLY's short-term assets ($3.94M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
KDLY's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.0M
Investing
-$2.1k
Financing
-$49.6k
KDLY's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
KDLY vs Health Information Service Stocks
Kindly MD Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.